Laimei Pharmaceuticals: 2024 performance forecast
Laimei Pharmaceuticals: Announcement on Abnormal Fluctuations in Stock Trading
Laimei Pharmaceutical: Announcement on the progress of the controlling shareholder\'s agreement to transfer part of the company\'s shares to the transferee
Laimei Pharmaceutical: Announcement on guaranteeing financing and credit for Chongqing Laimei Longyu Pharmaceutical Co., Ltd.
Laimei Pharmaceutical: Announcement of Resolutions of the 35th Meeting of the Fifth Board of Supervisors
Laimei Pharmaceutical: Announcement of Resolutions of the 41st Meeting of the Fifth Board of Directors
Laimei Pharmaceutical: Announcement on the results of the first instance judgment on the wholly-owned subsidiary lawsuit
Laimei Pharmaceutical: Announcement on participating in the tenth batch of national centralized drug procurement to be selected
Laimei Pharmaceutical: Announcement on the Controlling Shareholder\'s Proposed Agreement to Transfer Part of the Company\'s Shares
Laimei Pharmaceutical: Legal Opinion of Beijing Zhonglun Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Chongqing Laimei Pharmaceutical Co., Ltd.
Laimei Pharmaceutical: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Laimei Pharmaceutical: Announcement on the inclusion of the company\'s products in the medical insurance catalogue
Laimei Pharmaceuticals: Laimei Pharmaceuticals Simplified Equity Change Report
Laimei Pharmaceuticals: Prompt Notice on Disclosure of Simplified Equity Change Report
Laimei Pharmaceutical: Proposed changes in the controlling shareholder and actual controller of the company
Laimei Pharmaceuticals: Notice on Obtaining Approval Notice for Drug Supplemental Applications
Laimei Pharmaceutical: Announcement on participating in the 2024 Online Investor Group Reception Day for Listed Companies in Chongqing
Laimei Pharmaceuticals: Announcement on the proposed change of accounting firm
Laimei Pharmaceuticals: Announcement on providing a guarantee extension for the loan of the participating company Condesay
Laimei Pharmaceutical: Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024